Glean stock $35.79 USD
Private-market facts for current and former Glean employees researching their stock.
Price per share sourced from public secondary-market data. Updated April 2026. Indicative only — not a live quote.
Overview
AI-powered enterprise search platform that connects to company apps and data to provide employees with relevant information and knowledge.
Glean outlook
For employees evaluating Glean equity, a 2x base multiple suggests limited near-term upside at current levels. The upside scenario at 3x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.
These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.
Selling Glean shares
Why shareholders consider selling
Shareholders in Glean may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Glean does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell Glean stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Artificial Intelligence sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Glean shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of Glean shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Artificial Intelligence market conditions, and any recent private-market transaction activity. Data points such as the company's Series E round, its reported $7B valuation and recent secondary-market pricing can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for Glean shareholders
Exploring equity in Glean often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
Glean most recently raised a Series E round in September 2024. The company was valued at $7B. Total funding raised to date is approximately $620M.
Lead investors in this round include Sequoia Capital and Lightspeed Venture Partners.
Founders & company background
Glean was founded in 2019 by Arvind Jain, T.R. Vishwanath, Piyush Prahladka, Tony Gentilcore and is headquartered in Palo Alto, CA.
Investors
Industry
Similar private companies
Latest Glean news
Frequently asked questions
- Is Glean still a private company?
- Yes, Glean is currently a private company.
- What is Glean's latest funding round?
- Glean's most recent known round is Series E, raised in September 2024.
- What is Glean's valuation?
- Glean's latest reported valuation is $7B.
- Who are the investors in Glean?
- Notable investors include Sequoia Capital, Lightspeed Venture Partners, General Catalyst, Kleiner Perkins, Datadog.
- Can I sell my Glean stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Glean stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · Glean data compiled from funding disclosures, investor announcements, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.